{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:03:33Z","timestamp":1769749413094,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004361","name":"Swiss Cancer League","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008307","name":"Promedica Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008307","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.xjidi.2021.100069","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T21:05:09Z","timestamp":1637787909000},"page":"100069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6081-9614","authenticated-orcid":false,"given":"Yun-Tsan","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4159-897X","authenticated-orcid":false,"given":"Desislava","family":"Ignatova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4710-0642","authenticated-orcid":false,"given":"Wolfram","family":"Hoetzenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2946-5576","authenticated-orcid":false,"given":"Steve","family":"Pascolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5379-2687","authenticated-orcid":false,"given":"Christina","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-8735","authenticated-orcid":false,"given":"Emmanuella","family":"Guenova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2021.100069_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-12-394300-2.00006-5","article-title":"Lymphocyte development: integration of DNA damage response signaling","volume":"116","author":"Bednarski","year":"2012","journal-title":"Adv Immunol"},{"key":"10.1016\/j.xjidi.2021.100069_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1159\/000509281","article-title":"Pathogenesis and therapy of primary cutaneous T cell lymphoma: Collegium Internationale Allergologicum (CIA) update 2020","volume":"181","author":"Bobrowicz","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.xjidi.2021.100069_bib3","doi-asserted-by":"crossref","first-page":"150018","DOI":"10.1098\/rsob.150018","article-title":"Ubiquitylation, neddylation and the DNA damage response","volume":"5","author":"Brown","year":"2015","journal-title":"Open Biol"},{"key":"10.1016\/j.xjidi.2021.100069_bib4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.xjidi.2021.100069_bib5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic\u00a0landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.xjidi.2021.100069_bib6","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.jid.5700199","article-title":"A\u00a0novel method for the isolation of skin resident T cells from normal and diseased human skin","volume":"126","author":"Clark","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100069_bib7","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2147\/CMAR.S138661","article-title":"Management of mycosis fungoides-type cutaneous T cell lymphoma (MF-CTCL): focus on chlormethine gel","volume":"11","author":"Denis","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.xjidi.2021.100069_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaad.2012.12.975","article-title":"Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma","volume":"69","author":"DeSimone","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100069_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/CCO.0000000000000161","article-title":"Recent advances in primary cutaneous T-cell lymphoma","volume":"27","author":"DeSimone","year":"2015","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.xjidi.2021.100069_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fmed.2020.00290","article-title":"Long-term disease control after allogeneic hematopoietic stem cell transplantation in primary cutaneous T-cell lymphoma; results from a single institution analysis","volume":"7","author":"Dimitriou","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.xjidi.2021.100069_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2133.2010.09812.x","article-title":"Malignant T cells in cutaneous T-cell lymphoma lesions contain decreased\u00a0levels of the antiapoptotic protein Ku70","volume":"163","author":"Ferenczi","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100069_bib13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jdcr.2020.05.031","article-title":"Evaluation and management of patients with early-stage mycosis fungoides who interrupt or discontinue topical mechlorethamine gel because of dermatitis","volume":"6","author":"Gilmore","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.xjidi.2021.100069_bib14","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1001\/jama.1984.03340410063036","volume":"251","author":"Goodman","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.xjidi.2021.100069_bib15","doi-asserted-by":"crossref","first-page":"10263","DOI":"10.1093\/nar\/gks824","article-title":"UVA-induced DNA double-strand breaks result from the repair of clustered oxidative DNA damages","volume":"40","author":"Greinert","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xjidi.2021.100069_bib17","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/bjd.18018","article-title":"Ingenol mebutate for mycosis fungoides","volume":"181","author":"Ignatova","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100069_bib18","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jaad.2019.12.070","article-title":"Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: preliminary findings from a prospective observational study","volume":"83","author":"Kim","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100069_bib19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1396-0296.2003.01640.x","article-title":"Management with topical nitrogen mustard in mycosis fungoides","volume":"16","author":"Kim","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.xjidi.2021.100069_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/2013.jamadermatol.541","article-title":"Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides","volume":"149","author":"Lessin","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.xjidi.2021.100069_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaad.2017.05.036","article-title":"Early clinical manifestations of Sezary syndrome: a multicenter retrospective cohort study","volume":"77","author":"Mangold","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2021.100069_bib22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/bjd.18089","article-title":"Characteristics associated with significantly worse quality of life in mycosis fungoides\/S\u00e9zary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study","volume":"182","author":"Molloy","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100069_bib23","series-title":"National Comprehensive Cancer Network. National Comprehensive Cancer Network clinical guidelines","year":"2021"},{"key":"10.1016\/j.xjidi.2021.100069_bib25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bjd.19252","article-title":"Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study [published correction appears in Br J Dermatol. 2021;185:685]","volume":"184","author":"Quaglino","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100069_bib26","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jid.2020.12.009","article-title":"Lack of systemic absorption of topical mechlorethamine gel in patients with mycosis fungoides cutaneous T-cell lymphoma","volume":"141","author":"Querfeld","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.xjidi.2021.100069_bib27","article-title":"Post-hoc analysis of a randomized, controlled, phase 2 study to assess response rates with chlormethine\/mechlorethamine gel in patients with stage IA\u2013IIA mycosis fungoides [e-pub ahead of print]","author":"Querfeld","year":"2021","journal-title":"Dermatology"},{"key":"10.1016\/j.xjidi.2021.100069_bib28","doi-asserted-by":"crossref","first-page":"1738797","DOI":"10.1080\/2162402X.2020.1738797","article-title":"Blockade of programmed cell death protein 1 (PD-1) in S\u00e9zary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation","volume":"9","author":"Saulite","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.xjidi.2021.100069_bib29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.17258","article-title":"The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients","volume":"181","author":"Scarisbrick","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2021.100069_bib30","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.xjidi.2021.100069_bib31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1586\/17512433.2014.944500","article-title":"Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T cell lymphoma","volume":"7","author":"Talpur","year":"2014","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.xjidi.2021.100069_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","article-title":"European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome - update 2017","volume":"77","author":"Trautinger","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.xjidi.2021.100069_bib33","doi-asserted-by":"crossref","first-page":"37647","DOI":"10.18632\/oncotarget.26479","article-title":"A\u00a0study of meiomitosis and novel pathways of genomic instability in cutaneous T cell lymphomas (CTCL)","volume":"9","author":"Tsang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.xjidi.2021.100069_bib34","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. [published correction appears in Blood. 2019;134:1112]","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"issue":"Suppl. 4","key":"10.1016\/j.xjidi.2021.100069_bib35","doi-asserted-by":"crossref","first-page":"iv30","DOI":"10.1093\/annonc\/mdy133","article-title":"Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Willemze","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.xjidi.2021.100069_bib36","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026721000709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026721000709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:02:16Z","timestamp":1763020936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026721000709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2667026721000709"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2021.100069","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2021.100069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100069"}}